Abeta deposits in older non-demented individuals with cognitive decline are indicative of preclinical Alzheimer's disease.
about
11 C-PIB-PET for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI)11 C-PIB-PET for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI)Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's diseaseConceptual evolution in Alzheimer's disease: implications for understanding the clinical phenotype of progressive neurodegenerative diseaseDrug Development in Alzheimer's Disease: The Contribution of PET and SPECTPreclinical Alzheimer disease: identification of cases at risk among cognitively intact older individualsMild cognitive impairment. Part 2: Biological markers for diagnosis and prediction of dementia in Alzheimer's diseaseBeta-amyloid deposition and the aging brainFunctional network endophenotypes unravel the effects of apolipoprotein E epsilon 4 in middle-aged adultsPET amyloid-beta imaging in preclinical Alzheimer's diseaseCognitive trajectories associated with β-amyloid deposition in the oldest-old without dementia.Disruption of functional connectivity in clinically normal older adults harboring amyloid burden.Longitudinal cognitive decline is associated with fibrillar amyloid-beta measured by [11C]PiBRepair of oxidative DNA damage, cell-cycle regulation and neuronal death may influence the clinical manifestation of Alzheimer's disease.Diagnosis and biomarkers of predementia in Alzheimer's disease.In vivo human amyloid imaging.Cortical binding of pittsburgh compound B, an endophenotype for genetic studies of Alzheimer's disease.Interactive effects of vascular risk burden and advanced age on cerebral blood flow.Functional neuroimaging in geriatric depression.Mapping brain beta-amyloid.Lack of association between 11C-PiB and longitudinal brain atrophy in non-demented older individuals.Changes in cognition.Relationship between memory performance and β-amyloid deposition at different stages of Alzheimer's disease.Failure to modulate attentional control in advanced aging linked to white matter pathology.Cost-effectiveness of magnetic resonance imaging with a new contrast agent for the early diagnosis of Alzheimer's disease.Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's diseaseFlorbetapir F 18 amyloid PET and 36-month cognitive decline: a prospective multicenter study.A blood-based predictor for neocortical Aβ burden in Alzheimer's disease: results from the AIBL study.Early detection of Alzheimer's disease using PiB and FDG PETNeural correlates of the interactive relationship between memory deficits and depressive symptoms in nondemented elderly: resting fMRI study.Longitudinal modeling of frontal cognition in APOE ε4 homozygotes, heterozygotes, and noncarriersCognitive reserve and Alzheimer's disease biomarkers are independent determinants of cognitionDepressive symptoms, brain volumes and subclinical cerebrovascular disease in postmenopausal women: the Women's Health Initiative MRI Study.Amyloid imaging and memory change for prediction of cognitive impairment.Pittsburgh compound B (11C-PIB) and fluorodeoxyglucose (18 F-FDG) PET in patients with Alzheimer disease, mild cognitive impairment, and healthy controlsPET amyloid imaging as a tool for early diagnosis and identifying patients at risk for progression to Alzheimer's diseaseAmyloid imaging as a biomarker for cerebral β-amyloidosis and risk prediction for Alzheimer dementia.Novel image-novel location object recognition task sensitive to age-related cognitive decline in nondemented elderly.Brain Amyloid Deposition and Longitudinal Cognitive Decline in Nondemented Older Subjects: Results from a Multi-Ethnic Population.APOE modifies the association between Aβ load and cognition in cognitively normal older adults.
P2860
Q24194742-E5DD6627-6892-4803-B035-CBFAEACE3F16Q24201039-705BEA19-C140-46B6-A2A6-8558E2288D6DQ24595802-CF8ED603-84A1-4646-B629-667AFBE03115Q24599735-D41E4F13-0633-4B7F-A504-A0B32BE8B283Q26749755-4FC86C7E-CBED-4A8F-AAD3-3481E7B365F8Q26995405-6C4F71C9-05E4-4424-9922-5B2851D49C61Q27027319-5BC35D5F-4D26-4DFE-83D2-9A204DBA7DBFQ28264556-B32F65CE-20E0-4E44-A66F-F919D280E945Q28394313-7F426EC0-0F71-41A3-A15D-0D6F47A06E53Q30040695-3D725F1C-716A-4E65-8C02-655D5BC4B106Q30413904-31E050C8-E38F-4A55-A897-378560A074FDQ30492809-6DCD8905-120D-4568-AEF6-51D42D0AC402Q33730370-1ED23777-CD08-4FED-803C-01EBCF630747Q33769079-8ACEF254-7160-4E09-8236-16674617796FQ33777509-49BF43E3-A3E8-4125-843A-268C350FB4BFQ33790277-79E6DD99-05F5-4745-8D24-DC84D6485F60Q33837669-3E85083D-3BBE-4E1B-9924-CD80A6CCE80DQ33851687-7F00B2DD-5308-4536-B0BB-56BF8C64A041Q33887659-A51BBE75-FE50-477E-9C9C-5DD83A671549Q33899600-775D544A-440B-44C9-9AFF-24AA59776E91Q34012320-9098B053-2C62-4BA9-A176-6BE36A27BC39Q34073106-DEF22F72-4277-4897-809D-5B119B6378CCQ34149444-00A44735-7E9D-4C45-9AE6-1D86EA6AB999Q34201217-E643189D-0326-488F-9DEC-3AEC881AC703Q34245127-6336966B-6AF5-4E2A-8393-FBFE13351F4AQ34247849-9D8387FB-9621-46C0-ABB9-B0E792DB75AEQ34333511-993A159D-F022-4ED4-9D8F-6B90C0F2633EQ34341870-6DBFFE74-AB3A-43B9-85A7-D094FC0AEEB7Q34483878-2AE64DF9-EC55-4CD1-BCCD-BF3585318885Q34709193-28F45F04-0999-4707-A881-AB75EF6B52F4Q34922644-FC2C6F6F-2782-48AA-9161-46E374CE1F1AQ34992153-5524B70C-2E96-418B-952F-ACEC35BDFF95Q35028141-747B8343-E11D-4F9A-BC17-A2040D13F99CQ35029095-1D7F2629-2305-4C6A-9D05-0FBA19F7ABC8Q35032948-3F5845F4-7AA7-45BA-9315-DB19F482F833Q35579225-31848E94-4296-4F5E-9282-1BA61C129DDFQ35600979-BF22BF0B-D38B-45E4-8864-32D8C49E1549Q35678134-C11AB36E-7FF4-4117-A7ED-0673B637EB48Q35722468-6CCF375B-BEA7-4E64-B5B7-E02B1520C96AQ35758673-E5417205-A20C-4E8A-A0D7-9F5430E40C8F
P2860
Abeta deposits in older non-demented individuals with cognitive decline are indicative of preclinical Alzheimer's disease.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Abeta deposits in older non-de ...... eclinical Alzheimer's disease.
@en
Abeta deposits in older non-de ...... eclinical Alzheimer's disease.
@nl
type
label
Abeta deposits in older non-de ...... eclinical Alzheimer's disease.
@en
Abeta deposits in older non-de ...... eclinical Alzheimer's disease.
@nl
prefLabel
Abeta deposits in older non-de ...... eclinical Alzheimer's disease.
@en
Abeta deposits in older non-de ...... eclinical Alzheimer's disease.
@nl
P2093
P50
P1433
P1476
Abeta deposits in older non-de ...... eclinical Alzheimer's disease.
@en
P2093
C L Masters
H Tochon-Danguy
U Ackermann
P304
P356
10.1016/J.NEUROPSYCHOLOGIA.2008.02.008
P577
2008-02-14T00:00:00Z